Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.

@article{Zeng2008ClinicalTE,
  title={Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.},
  author={Juan Zeng and Yun-Qing Li and X-L Zuo and Y X Zhen and Jin-huan Yang and C Liu},
  journal={Alimentary pharmacology & therapeutics},
  year={2008},
  volume={28 8},
  pages={994-1002}
}
BACKGROUND The intestinal permeability is increased in patients with diarrhoea-predominant irritable bowel syndrome (D-IBS). AIM To determine the possible efficacy of lactic acid bacteria on the increased intestinal permeability in D-IBS. METHODS Treatment was employed for 4 weeks in a randomized single blind placebo controlled study with 30 D-IBS patients. Patients were given either probiotic fermented milk (Streptococcus thermophilus, Lactobacillus bulgaricus, Lactobacillus acidophilus… CONTINUE READING